Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 54

Sort by

Sort Order Select

Journal Articles

Phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia

Blood blood.2025030722.

https://doi.org/10.1182/blood.2025030722

Published: 2026

Includes: Supplemental data

Journal Articles

Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial

Blood blood.2025030816.

https://doi.org/10.1182/blood.2025030816

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world experience with IDH inhibitors in Acute Myeloid Leukemia: A german multicenter analysis with a focus on differentiation syndrome

Krischan Braitsch, Karin Huber, Andrew Berdel, Lydia Kretschmer, Adrian Gottschlich, Tim Lohmann, Kathrin Rieger, Karsten Spiekermann, Thomas Schroeder, Silke Kapp-Schwoerer, Mareike Verbeek, Florian Bassermann, Hartmut Döhner, Tim Sauer, Christoph Röllig, Jan-Henrik Mikesch, Franziska Westendorf, Lars Fransecky, Katharina S. Götze

Blood (2025) 146 (Supplement 1): 2846.

https://doi.org/10.1182/blood-2025-2846

Published: 2025

Journal Articles

Does stringent cytoreduction improve survival in myeloproliferative chronic myelomonocytic leukemia? a correlative study on the dacota trial.

Blood (2025) 146 (Supplement 1): 791.

https://doi.org/10.1182/blood-2025-791

Published: 2025

Journal Articles

Vexas syndrome in Germany: Insights from a prospective registry on clinical presentation, management and outcomes

Blood (2025) 146 (Supplement 1): 4968.

https://doi.org/10.1182/blood-2025-4968

Published: 2025

Journal Articles

A phase II study evaluating the efficacy and safety of imetelstat in patients with advanced myelodysplastic neoplasms or AML failing HMA-based therapy – interim analysis results of the IMpress study

Lionel Ades, Steven Lane, Alice Garnier, Thomas Cluzeau, Odile Rauzy, Katharina S. Götze, Aristoteles Giagounidis, Deepak Singhal, Dominic Brauer, Carolyn Grove, Katharina Mohr, Fatiha Chermat, Joanna Nkyekyer, Uwe Platzbecker

Blood (2025) 146 (Supplement 1): 5155.

https://doi.org/10.1182/blood-2025-5155

Published: 2025

Journal Articles

Wide variability and inconsistency in reporting of results of Myelodysplastic Syndromes/neoplasms (MDS) clinical trials: An icMDS systematic review of published manuscripts

Ted Getz, Kelly Pugh, Andrew Brunner, Jan Philipp Bewersdorf, Amy DeZern, Tariq Kewan, Uma Borate, Uwe Platzbecker, Mikkael Sekeres, Andrew Wei, Shahram Kordasti, Rena Buckstein, Gail Roboz, Michael Savona, Sanam Loghavi, Robert Hasserjian, Pierre Fenaux, David Sallman, Christopher Hourigan, Matteo Della Porta, Stephen Nimer, Richard Little, Valeria Santini, Fabio Efficace, Justin Taylor, Olatoyosi Odenike, Tae Kon Kim, Stephanie Halene, Rami Komrokji, Elizabeth Griffiths, Peter Greenberg, Mina Xu, Zhuoer Xie, Rafael Bejar, Guillermo Sanz, Mrinal Patnaik, Maria E. Figueroa, Hetty Carraway, Omar Abdel-Wahab, Daniel Starczynowski, Eric Padron, Jacqueline Boultwood, Steven Gore, Naval Daver, Jane Churpek, Ravi Majeti, John Bennett, Alan List, Adrian Mosquera Orgueira, Klaus Metzeler, Francesc Sole, Lisa Pleyer, Arjan Van de Loosdrecht, Thomas Cluzeau, David Steensma, Ghulam Mufti, Lionel Ades, Luca Lanino, Yazan Madanat, Anne Sophie Kubasch, Marie Sebert, R. Coleman Lindsley, Katharina S. Götze, Carmelo Gurnari, Yasushi Miyazaki, Aref Al-Kali, Abdulraheem Yacoub, Bing Li, Ioannis Kotsianidis, Maximilian Stahl, Amer Zeidan

Blood (2025) 146 (Supplement 1): 3852.

https://doi.org/10.1182/blood-2025-3852

Published: 2025

Journal Articles

Therapy-induced senescence reprograms non-M3 AML into a drug-exploitable APL-like state

Martin Schönlein, Wencke Walter, Paulina Richter-Pechanska, Katharina Barbara Rösel, Diego Gilioli, Zhiting Shao, Jana Ihlow, Karsten Spiekermann, Katharina S. Götze, Soyoung Lee, Yong Yu, Torsten Haferlach, Hugues De Thé, Raffaella Di Micco, Clemens Schmitt

Blood (2025) 146 (Supplement 1): 3244.

https://doi.org/10.1182/blood-2025-3244

Published: 2025

Journal Articles

Venetoclax combined with five days of azacitidine for the treatment of previously untreated Acute Myeloid Leukemia (AML): Initial results of the prospective venaza-5S trial

Klaus Metzeler, Jens Przybilla, Anne Weigert, Mathias Hänel, Thomas Illmer, Julia Pross, Alexander Höllein, Martin Schmidt-Hieber, Ullrich Graeven, Tim Sauer, Stefan Neuburger, Katharina S. Götze, Dominic Brauer, Madlen Jentzsch, Christoph Röllig, Dirk Hasenclever, Uwe Platzbecker

Blood (2025) 146 (Supplement 1): 46.

https://doi.org/10.1182/blood-2025-46

Published: 2025

Journal Articles

Unleashing intrinsic inflammation in AML using therapeutic cytokines overcomes pro-survival pathways and induces deep and durable remission In Vivo.

Blood (2025) 146 (Supplement 1): 3280.

https://doi.org/10.1182/blood-2025-3280

Published: 2025

Journal Articles

Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE 2 signaling in NK cells

Blood (2025) 145 (13): 1395–1406.

https://doi.org/10.1182/blood.2024025706

Published: 2025

Includes: Supplemental data

Journal Articles

Single Cell Multiomic Analysis of Bone Marrow Hematopoietic Stem/Progenitor Cells from Individuals with Clonal Hematopoiesis Reveals Potential Mechanisms of Anemia Development

Michele C Buck, Jennifer Rivière, Anna Navarro Figueredo, Daniele Scarcella, Maximilian Buser, Judith S. Hecker, Mark van der Garde, Carsten Marr, Katharina S. Götze

Blood (2024) 144 (Supplement 1): 2666.

https://doi.org/10.1182/blood-2024-211093

Published: 2024

Journal Articles

Omitting Ciprofloxacin Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Does Not Result in Inferior Outcomes

Krischan Braitsch, Vanessa Nehrbaß, Katharina Nickel, Maike Hefter, Katrin Koch, Kathrin Rothe, Florian Bassermann, Jochen Schneider, Katharina S. Götze, Peter Herhaus, Mareike Verbeek

Blood (2024) 144 (Supplement 1): 3513.

https://doi.org/10.1182/blood-2024-210620

Published: 2024

Journal Articles

Single-Cell Transcriptomics of Bone Marrow Mesenchymal Stromal Cells Identifies Altered CLCF1 Signaling in DNMT3A -Mutated Clonal Hematopoiesis

Anna Navarro Figueredo, Daniele Scarcella, Michele C Buck, Maximilian Buser, Jennifer Rivière, Michael Sterr, Wencke Walter, Priyansh Srivastava, Judith S. Hecker, Ana Conesa, Mark van der Garde, Carsten Marr, Katharina S. Götze

Blood (2024) 144 (Supplement 1): 2676.

https://doi.org/10.1182/blood-2024-210254

Published: 2024

Journal Articles

Mesenchymal Stromal Cells from Individuals with DNMT3A mut Clonal Hematopoiesis Instruct Young Healthy Hematopoietic Stem/Progenitor Cells Towards a Myeloid-Biased Aging Phenotype Resembling That of Patients with Clonal Cytopenia of Undetermined Significance (CCUS)

Anna Navarro Figueredo, Wencke Walter, Jennifer Rivière, Marit Leilich, Siddhi Pawar, Michèle Buck, Judith S. Hecker, Marta Benegas Coll, Carolina Monzó, Maki Sakuma, Priyansh Srivastava, Ana Conesa, Torsten Haferlach, Mark Van Der Garde, Katharina S. Götze

Blood (2023) 142 (Supplement 1): 2703.

https://doi.org/10.1182/blood-2023-188781

Published: 2023

Journal Articles

Flipping the switch in the stem cell niche

Katharina S. Götze

Blood (2023) 142 (5): 404–406.

https://doi.org/10.1182/blood.2023021286

Published: 2023

Journal Articles

Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML

Blood (2023) 141 (9): 1023–1035.

https://doi.org/10.1182/blood.2021015246

Published: 2023

Includes: Supplemental data

Journal Articles

Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress

Blood (2022) 139 (5): 690–703.

https://doi.org/10.1182/blood.2021011775

Published: 2022

Includes: Supplemental data

Journal Articles

Midostaurin Plus Intensive Chemotherapy for Younger and Older Patients with Acute Myeloid Leukemia and FLT3 Internal Tandem Duplications

Blood (2021) 138 (Supplement 1): 692.

https://doi.org/10.1182/blood-2021-147256

Published: 2021

Journal Articles

CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease

Blood (2021) 138 (18): 1727–1732.

https://doi.org/10.1182/blood.2020010163

Published: 2021

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia

Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial

Real-world experience with IDH inhibitors in Acute Myeloid Leukemia: A german multicenter analysis with a focus on differentiation syndrome

Does stringent cytoreduction improve survival in myeloproliferative chronic myelomonocytic leukemia? a correlative study on the dacota trial.

Vexas syndrome in Germany: Insights from a prospective registry on clinical presentation, management and outcomes

A phase II study evaluating the efficacy and safety of imetelstat in patients with advanced myelodysplastic neoplasms or AML failing HMA-based therapy – interim analysis results of the IMpress study

Wide variability and inconsistency in reporting of results of Myelodysplastic Syndromes/neoplasms (MDS) clinical trials: An icMDS systematic review of published manuscripts

Therapy-induced senescence reprograms non-M3 AML into a drug-exploitable APL-like state

Venetoclax combined with five days of azacitidine for the treatment of previously untreated Acute Myeloid Leukemia (AML): Initial results of the prospective venaza-5S trial

Unleashing intrinsic inflammation in AML using therapeutic cytokines overcomes pro-survival pathways and induces deep and durable remission In Vivo.

Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE 2 signaling in NK cells

Single Cell Multiomic Analysis of Bone Marrow Hematopoietic Stem/Progenitor Cells from Individuals with Clonal Hematopoiesis Reveals Potential Mechanisms of Anemia Development

Omitting Ciprofloxacin Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Does Not Result in Inferior Outcomes

Single-Cell Transcriptomics of Bone Marrow Mesenchymal Stromal Cells Identifies Altered CLCF1 Signaling in DNMT3A -Mutated Clonal Hematopoiesis

Mesenchymal Stromal Cells from Individuals with DNMT3A mut Clonal Hematopoiesis Instruct Young Healthy Hematopoietic Stem/Progenitor Cells Towards a Myeloid-Biased Aging Phenotype Resembling That of Patients with Clonal Cytopenia of Undetermined Significance (CCUS)

Flipping the switch in the stem cell niche

Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML

Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress

Midostaurin Plus Intensive Chemotherapy for Younger and Older Patients with Acute Myeloid Leukemia and FLT3 Internal Tandem Duplications

CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only